The world of health tech is buzzing, and if you're a startup founder, you know this is your moment. But big ideas need big backing. That’s where the right venture capital firm comes in — not just for funding, but for guidance, connections, and a clear path to scaling.
In this article, we’re diving into four influential healthtech venture capital firms you should consider pitching to in 2025. Whether you’re building AI-driven diagnostics, consumer health apps, or breakthrough medical devices, these VCs can offer the support you need to turn your vision into reality.
1. OrbiMed
OrbiMed is a global powerhouse in healthcare investing, with a focus on driving innovation across biopharmaceuticals, medical devices, diagnostics, and healthcare technology. With over 25 years of experience, OrbiMed has helped launch more than 90 life sciences startups and has been instrumental in bringing over 60 new therapies to market.
Investment Approach
OrbiMed adopts a versatile investment strategy, offering support across three main areas:
- Private Equity: Funding startups to growth-stage companies, often taking a lead investor role.
- Private Credit/Royalty: Providing non-dilutive capital to commercial-stage companies and monetizing royalty streams.
- Public Equity: Investing in publicly traded healthcare companies, from biopharma to medical devices.
Global Reach and Impact
OrbiMed’s commitment goes beyond funding. The firm has invested over $2 billion in healthcare across developing countries, supporting initiatives like maternal care in India and dialysis centers in China. This global perspective, combined with deep industry expertise, makes OrbiMed a top choice for health tech startups looking to scale.
Notable Investments
OrbiMed’s portfolio is a testament to its industry leadership, featuring companies like AbCellera, Acelyrin, Acutus Medical, and Adaptive Biotechnologies. Startups partnering with OrbiMed gain access to a wealth of experience and a vast network, positioning them for rapid growth.
2. SOSV
SOSV is a global venture capital firm with a mission to advance human and planetary health through deep tech innovation. With nearly 1,000 startups across 56 countries, SOSV provides early-stage funding and robust support through its flagship programs, IndieBio and HAX.
Investment Approach
- IndieBio: A life sciences accelerator focused on health, sustainability, and food tech. IndieBio offers pre-seed funding ($250,000-$525,000) along with mentorship and lab access.
- HAX: A pre-seed program for hardware startups, including health tech, with $500,000 in funding and access to design and engineering teams in Shenzhen, Pune, and other global locations.
Global Impact
SOSV’s influence extends beyond funding, with a diverse network of founders from 84 nationalities, and a strong commitment to underrepresented regions (30% of founders from low- to middle-income countries). As of 2024, SOSV manages $1.5 billion in assets and has backed industry leaders like NotCo, Upside Foods, OpenTrons, and Perfect Day.
Notable Investments
SOSV’s health-focused portfolio includes companies like NotCo (plant-based food tech), R-Zero (UV-C disinfection), OpenTrons (lab automation), and Geltor (sustainable biomaterials). Startups in SOSV’s ecosystem gain access to a vast global network and specialized expertise, making it an ideal partner for scaling health tech innovations.
3. Flare Capital Partners
Flare Capital Partners is a venture capital firm with a mission to transform the business of healthcare by partnering with exceptional founders and leveraging its deep industry expertise. The firm is known for its strong connections across the healthcare ecosystem, including providers, payers, and pharmaceutical companies.
Investment Approach
Flare Capital supports startups at all stages of their journey:
- Early Stage: Assisting founders with team building, product development, and early market validation.
- Growth Stage: Scaling operations through customer acquisition, product expansion, and talent sourcing.
- Late Stage: Focusing on strategic opportunities, including capital raises, product line extensions, and potential exits.
Expertise and Network
Flare Capital’s team consists of seasoned investors, clinicians, and technologists who understand the complexities of healthcare. Their network of over three dozen healthcare organizations helps startups achieve commercial validation and scale faster.
Notable Investments
Flare Capital’s portfolio includes standout companies like Aetion, Aspen RxHealth, Cohere Health, and Bright Health Group. By providing not just funding but also strategic guidance, Flare Capital is an ideal partner for health tech startups aiming to disrupt the industry.
4. 7wire Ventures
7wire Ventures is a venture capital firm dedicated to empowering health consumers through technology, creating a healthcare ecosystem where individuals become active participants in their own care.
Investment Approach
7wire Ventures focuses on consumer-driven healthcare solutions by:
- Empowering Consumers: Backing startups that transform patients into informed, connected health consumers.
- Digital Health Focus: Investing in tech-driven solutions that make healthcare more accessible, engaging, and efficient.
- Early and Growth Stages: Supporting startups at various stages, from inception to scaling.
Strategic Values
7wire Ventures is guided by principles of accessibility, empathy, and empowerment, ensuring that its portfolio companies offer impactful, user-centered solutions.
Notable Investments
7wire Ventures’ portfolio includes companies like 9amHealth (diabetes care), Brightline (behavioral health for children), MedArrive (at-home care for vulnerable populations), and Jasper (cancer care navigation). Startups partnering with 7wire gain access to a network of industry experts and a focus on scalable consumer health solutions.
Edited by Harshajit Sarmah
